X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-05-01 | ACI | Larson Robert Bruce | SVP, Chief Accounting Officer | S - Sale | $20.24 | -24,362 | 50,241 | -33% | -$493,087 | ||||||
2024-04-30 | ACI | Dhanda Anuj | Chief Tech,Transformation Off | S - Sale | $20.35 | -100,000 | 365,297 | -21% | -$2,035,000 | ||||||
2023-04-27 | ACI | Larson Robert Bruce | Chief Accounting Officer | S - Sale | $20.95 | -32,544 | 50,241 | -39% | -$681,797 | ||||||
| A | 2023-01-25 | ACI | Gajial Omer | EVP, Health, Chief Dig Office | S - Sale | $21.05 | -36,000 | 20,042 | -64% | -$757,800 | |||||
| A | 2023-01-25 | ACI | Gajial Omer | EVP, Health, Chief Dig Office | S - Sale | $21.05 | -36,000 | 18,356 | -66% | -$757,800 | |||||
2023-01-25 | ACI | Gajial Omer | EVP, Pharmacy, Health | S - Sale | $21.05 | -36,000 | 25,140 | -59% | -$757,800 | ||||||
2023-01-25 | ACI | Larson Robert Bruce | Chief Accounting Officer | S - Sale | $21.01 | -30,000 | 50,241 | -37% | -$630,300 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |